RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast Cancer
© 2017. Introduction: Sorafenib is a multikinase inhibitor with antiangiogenic/antiproliferative activity. In this randomized, double-blind, placebo-controlled phase III trial we assessed first- or second-line capecitabine with sorafenib or placebo in patients with locally advanced/metastatic HER2-n...
| Main Authors: | Baselga, J., Zamagni, C., Gómez, P., Bermejo, B., Nagai, S., Melichar, B., Chan, Arlene, Mángel, L., Bergh, J., Costa, F., Gómez, H., Gradishar, W., Hudis, C., Rapoport, B., Roché, H., Patricia, M., Huang, L., Meinhardt, G., Zhang, J., Schwartzberg, L. |
|---|---|
| Format: | Journal Article |
| Published: |
2017
|
| Online Access: | http://hdl.handle.net/20.500.11937/58524 |
Similar Items
Capecitabine and vinorelbine in metastatic breast cancer
by: Chan, Arlene, et al.
Published: (2009)
by: Chan, Arlene, et al.
Published: (2009)
Phase II study of a triple combination of oral vinorelbine, capecitabine and trastuzumab as first-line treatment in HER2-positive metastatic breast cancer
by: Chan, Arlene, et al.
Published: (2013)
by: Chan, Arlene, et al.
Published: (2013)
Simvastatin sensitizes human gastric cancer xenograft in nude mice to capecitabine by suppressing nuclear factor-kappa B-regulated gene products
by: Manu, K., et al.
Published: (2013)
by: Manu, K., et al.
Published: (2013)
Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial
by: Middleton, Gary, et al.
Published: (2014)
by: Middleton, Gary, et al.
Published: (2014)
First evidence that γ-tocotrienol inhibits the growth of human gastric cancer and chemosensitizes it to capecitabine in a xenograft mouse model through the modulation of NF-κB pathway
by: Manu, K., et al.
Published: (2012)
by: Manu, K., et al.
Published: (2012)
Identification of a thalidomide derivative that selectively targets tumorigenic liver progenitor cells and comparing its effects with lenalidomide and sorafenib
by: Woo, K., et al.
Published: (2016)
by: Woo, K., et al.
Published: (2016)
Fabrication and characterization of nanodelivery platform based on Chitosan to improve the anticancer outcome of sorafenib in Hepatocellular Carcinoma
by: Albalawi, Fahad, et al.
Published: (2023)
by: Albalawi, Fahad, et al.
Published: (2023)
Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer
by: Miles, D., et al.
Published: (2010)
by: Miles, D., et al.
Published: (2010)
Randomized Phase 111 Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endrocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
by: Wolff, A., et al.
Published: (2013)
by: Wolff, A., et al.
Published: (2013)
Randomized phase III placebo-controlled trial of letrozole plus oral temsirolimus as first-line endocrine therapy in postmenopausal women with locally advanced or metastatic breast cancer
by: Wolff, A., et al.
Published: (2013)
by: Wolff, A., et al.
Published: (2013)
Glutamine supplementation in cystic fibrosis: a randomized placebo-controlled trial
by: Forrester, Doug L., et al.
Published: (2015)
by: Forrester, Doug L., et al.
Published: (2015)
Effect of Aspirin vs Placebo on the Prevention of Depression in Older People: A Randomized Clinical Trial
by: Berk, M., et al.
Published: (2020)
by: Berk, M., et al.
Published: (2020)
Synthesis and characterization of chitosan-based nanodelivery systems to enhance the anticancer effect of Sorafenib drug in Hepatocellular Carcinoma and Colorectal Adenocarcinoma cell lines
by: Ruman, Umme, et al.
Published: (2021)
by: Ruman, Umme, et al.
Published: (2021)
Synthesis and cytotoxicity evaluation of sorafenib- and 5-fluorouracil-loaded chitosan, graphene-oxide and folic-acid based nanocarriers for liver and colon cancer
by: Ruman, Umme
Published: (2021)
by: Ruman, Umme
Published: (2021)
Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline.
by: Ryan, Joanne, et al.
Published: (2020)
by: Ryan, Joanne, et al.
Published: (2020)
Public-private roles in broadband infrastructure deployment: an introduction
by: Gómez-Barroso, J.L., et al.
Published: (2009)
by: Gómez-Barroso, J.L., et al.
Published: (2009)
A 2-year randomised placebo-controlled trial of doxycycline for lymphangioleiomyomatosis
by: Chang, William Y.C., et al.
Published: (2014)
by: Chang, William Y.C., et al.
Published: (2014)
A meta-analysis of randomized placebo-controlled treatment trials for depression and anxiety in Parkinson’s disease
by: Troeung, L., et al.
Published: (2013)
by: Troeung, L., et al.
Published: (2013)
Evidence-based medicine, "placebos" and the homeopathy controversy
by: Turner, Andrew James
Published: (2012)
by: Turner, Andrew James
Published: (2012)
Short-Term Effects of Mulligan Mobilization With Movement on Pain, Disability, and Kinematic Spinal Movements in Patients With Nonspecific Low Back Pain: A Randomized Placebo-Controlled Trial
by: Hidalgo, B., et al.
Published: (2015)
by: Hidalgo, B., et al.
Published: (2015)
Sperm preparation and egg activation for bovine Intra-Cytoplasmic Sperm Injection (ICSI)
by: Gómez-Martínez, J.
Published: (2019)
by: Gómez-Martínez, J.
Published: (2019)
Oral ketamine vs placebo in patients with cancer-related neuropathic pain
by: Fallon, Marie T., et al.
Published: (2018)
by: Fallon, Marie T., et al.
Published: (2018)
TILs in metastatic breast cancer—no surprises, but more questions
by: Chan, Arlene
Published: (2017)
by: Chan, Arlene
Published: (2017)
Supplemented zinc does not alter mood in healthy older European adults--a randomised placebo-controlled trial: the Zenith study
by: Stewart-Knox, B., et al.
Published: (2011)
by: Stewart-Knox, B., et al.
Published: (2011)
A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin
by: Zin, Che Suraya, et al.
Published: (2010)
by: Zin, Che Suraya, et al.
Published: (2010)
A randomized, placebo-controlled trial of cenicriviroc for
treatment of nonalcoholic steatohepatitis with fibrosis
by: Friedman, Scott L., et al.
Published: (2018)
by: Friedman, Scott L., et al.
Published: (2018)
A comparative study of different induction techniques
(Propofol-Placebo, Propofol-Ephedrine and Propofol-
Placebo-Crystalloid) on intubating conditions after
rocuronium administration
by: Muhd Helmi Azmi,, et al.
Published: (2007)
by: Muhd Helmi Azmi,, et al.
Published: (2007)
Comparison of the effect of ginger and zinc sulfate on primary dysmenorrhea: A placebo-controlled randomized trial
by: Kashefi, F., et al.
Published: (2014)
by: Kashefi, F., et al.
Published: (2014)
Attentional bias modification training for insomnia: A double-blind placebo controlled randomized trial
by: Lancee, J., et al.
Published: (2017)
by: Lancee, J., et al.
Published: (2017)
Phylogeography of the reef fish Cephalopholis argus (Epinephelidae) indicates Pleistocene isolation across the indo-pacific barrier with contemporary overlap in the coral triangle
by: Gaither, M., et al.
Published: (2011)
by: Gaither, M., et al.
Published: (2011)
A randomised double-blind placebo-controlled trial of the impact of high-dose statins on the ischaemia-reperfusion injury in elective AAA repair
by: Abdul Rahman, Mohd Norhisham Azmi, et al.
Published: (2009)
by: Abdul Rahman, Mohd Norhisham Azmi, et al.
Published: (2009)
The IRONMAN trial: a protocol for a multicentre randomised placebo-controlled trial of intravenous iron in intensive care unit patients with anaemia
by: Litton, E., et al.
Published: (2014)
by: Litton, E., et al.
Published: (2014)
HER2 positive metastatic breast cancer: What happens after first line failure?
by: Chan, Arlene
Published: (2016)
by: Chan, Arlene
Published: (2016)
Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): A multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
by: Chan, Arlene, et al.
Published: (2016)
by: Chan, Arlene, et al.
Published: (2016)
Midodrine as adjunctive support for treatment of refractory hypotension in the intensive care unit: A multicenter, randomized, placebo controlled trial (the MIDAS trial)
by: Anstey, Matthew, et al.
Published: (2017)
by: Anstey, Matthew, et al.
Published: (2017)
Randomized placebo-controlled trial assessing the effect of 24-week fenofibrate therapy on circulating markers of abdominal aortic aneurysm: Outcomes from the FAME-2 trial
by: Pinchbeck, J., et al.
Published: (2018)
by: Pinchbeck, J., et al.
Published: (2018)
Intravenous iron or placebo for anaemia in intensive care: the IRONMAN multicentre randomized blinded trial: A randomized trial of IV iron in critical illness
by: The, I., et al.
Published: (2016)
by: The, I., et al.
Published: (2016)
Randomized Phase 11 Study of the Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatis Triple-Negative Breast Cancer
by: Baselga, J., et al.
Published: (2013)
by: Baselga, J., et al.
Published: (2013)
Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review
by: Chow, C., et al.
Published: (2017)
by: Chow, C., et al.
Published: (2017)
Leadership in implementation
by: Kraatz, J., et al.
Published: (2016)
by: Kraatz, J., et al.
Published: (2016)
Similar Items
-
Capecitabine and vinorelbine in metastatic breast cancer
by: Chan, Arlene, et al.
Published: (2009) -
Phase II study of a triple combination of oral vinorelbine, capecitabine and trastuzumab as first-line treatment in HER2-positive metastatic breast cancer
by: Chan, Arlene, et al.
Published: (2013) -
Simvastatin sensitizes human gastric cancer xenograft in nude mice to capecitabine by suppressing nuclear factor-kappa B-regulated gene products
by: Manu, K., et al.
Published: (2013) -
Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial
by: Middleton, Gary, et al.
Published: (2014) -
First evidence that γ-tocotrienol inhibits the growth of human gastric cancer and chemosensitizes it to capecitabine in a xenograft mouse model through the modulation of NF-κB pathway
by: Manu, K., et al.
Published: (2012)